InvestmentUpdated on 9 November 2025
Investment opportunity in personalized midlife health
Founder | Perimenopause | Women's Health at TEVIA®
Marghita, Romania
About
Early-stage digital health initiative focused on optimizing women’s wellbeing during hormonal transition, through data-driven personalization and clinically validated solutions.
The project aims to build partnerships with investors and innovation funds supporting scalable models that integrate digital assessment, clinical research and applied nutraceutical development.
Objectives include accelerating validation, expanding scientific collaborations and preparing for international market entry.
Stage
- Seed and Development
- Startup
Applies to
- BIOLOGY / BIOTECHNOLOGY
- E-HEALTH
- INTELLECTUAL PROPERTY, LEGAL AND FINANCIAL SERVICES
- LIFE SCIENCE
- THERAPEUTIC AREA
Organisation
Similar opportunities
Project cooperation
Clinical and research partnerships in women’s health
- Strategic Partner
- Technological contribution
- Finding Partners - Completing consortia
Camelia Ghiulai
Founder | Perimenopause | Women's Health at TEVIA®
Marghita, Romania
Investment
- Startup
- Seed and Development
- BIOLOGY / BIOTECHNOLOGY
- INTELLECTUAL PROPERTY, LEGAL AND FINANCIAL SERVICES
Rodrigo de Pablos
CEO at Bioreplica
Las Palmas, Spain
Service
- Certification
- INTELLECTUAL PROPERTY, LEGAL AND FINANCIAL SERVICES
Barend Smet
President at Thaumatec Tech Group
Poland